American Well Corp Stock Price, News & Analysis

Amwell® (NYSE: AMWL), a digital care leader, has announced it will release its third quarter 2024 operating results on Wednesday, October 30. Following the earnings alert distribution, the company's management team will host a live conference call and webcast at 5 p.m. ET to discuss the results and provide a business update. Investors can access the full earnings report and live audio webcast through the Investors section of Amwell's website. A replay of the webcast will be available at investors.amwell.com for approximately 90 days after the call.

Amwell (NYSE: AMWL) has announced a partnership with Hello Heart, integrating the digital preventive heart health solution into its clinical programs portfolio on the Amwell Converge™ platform. This collaboration allows Amwell health plan clients to offer their employer accounts Hello Heart's cardiovascular solution to eligible members with high blood pressure, high cholesterol, or other cardiovascular disease risk factors.

Members can access Hello Heart's solution through their existing Amwell-powered offering, alongside virtual primary care, urgent care, behavioral health, and other clinical programs. The program provides users with a connected blood pressure monitor and an app offering personalized daily coaching and metric tracking. This integration aims to address the clinical and financial burden of heart disease, which costs health plans an average of $12,500 per member per year.

Amwell (NYSE: AMWL), a leader in hybrid care enablement, has announced its participation in several investor conferences this September. Key events include:

• Morgan Stanley 22nd Annual Global Healthcare Conference in New York City on September 4, featuring a fireside chat at 1:50 p.m. ET

• Wells Fargo Healthcare Conference in Boston on September 5 (one-on-one meetings only)

• Baird Healthcare Conference in New York City on September 10, with one-on-one investor meetings

• TD Cowen 9th Annual FutureHealth Conference in New York City on September 10, including a panel discussion at 2:20 p.m. ET

Ido Schoenberg, M.D., Amwell's chairman and CEO, and Robert Shepardson, CFO, will represent the company. Audio webcasts of the Morgan Stanley fireside chat and TD Cowen panel will be available at investors.amwell.com.

Amwell (NYSE: AMWL), a small-cap growth healthcare company specializing in healthcare software as a service, has released its financial results for the second quarter of 2024, ending June 30. The company has made the detailed earnings report available on its investor relations website. Amwell will host a conference call on July 31, 2024, at 5 p.m. ET to discuss the financial results. Interested parties can access the call via a live audio webcast or by dialing in, with separate numbers provided for U.S. and international participants. A replay of the call will be available on the company's website after the event concludes.

Amwell® (NYSE: AMWL), a leader in hybrid care enablement, has announced it will report its second quarter 2024 operating results on Wednesday, July 31. The company will host a live conference call and webcast at 5 p.m. ET on the same day to review the results and provide a general business update. Investors can access the audio webcast through the Investors section of Amwell's website or join the conference call using the provided phone numbers. A replay of the webcast will be available at investors.amwell.com for approximately 90 days after the event.

Amwell (NYSE: AMWL) announced a 1-for-20 reverse stock split of its Class A, B, and C common stock, effective on July 10, 2024, at 5:00 p.m. EDT. Trading on a split-adjusted basis will commence on July 11, 2024, under the same symbol, 'AMWL'.

The primary objective is to comply with the NYSE's $1.00 minimum average closing price requirement. This action will reduce the number of issued and outstanding shares across all classes by a factor of 20, without affecting the company's market capitalization.

Shareholders approved the reverse split at Amwell's annual meeting on June 18, 2024, choosing a split ratio between 1-for-10 and 1-for-20, with the final decision made by the Board on June 27, 2024. No fractional shares will be issued; instead, cash payments will be made for fractional entitlements.

The new CUSIP number for Class A shares will be 03044L 204 post-split. All outstanding options, warrants, and equity incentive plans will be adjusted accordingly. The par value remains unchanged at $0.01 per share.

Amwell (NYSE: AMWL), a leader in hybrid care enablement, announced the appointment of Ricky Goldwasser to its Board of Directors, effective June 13, 2024. Goldwasser, with a strong financial background and a successful career in healthcare investment and research, is expected to guide Amwell towards profitability and efficient cash flow. She replaces Deval Patrick, a long-time board member who played a important role in Amwell’s IPO and telehealth acceptance. CEO Ido Schoenberg highlighted Goldwasser's potential to help Amwell achieve its goals in the evolving healthcare landscape.

Amwell (NYSE: AMWL) announced that co-founder Roy Schoenberg is transitioning from his role as president and co-CEO to become Executive Vice Chairman of the Board. Ido Schoenberg will now serve as the sole CEO. Roy Schoenberg has been instrumental in the growth of Amwell, guiding the company through the COVID-19 pandemic and expanding its platform to over 100,000 active clinicians and millions of patients globally. He also spearheaded the development of the Amwell Converge platform aimed at integrating in-person and digital healthcare. The transition marks a shift from extensive R&D to a focus on operational efficiency, cash flow optimization, and profitable growth.

Amwell (NYSE: AMWL) announced that its Co-CEO and President, Roy Schoenberg, will speak at the Disability & Telehealth Conference on May 18, 2024, at 12:15 PST. The virtual conference will discuss barriers to telehealth for those with disabilities and innovative solutions for healthcare accessibility. Schoenberg will join leaders from Stanford Medicine, Stanford Health Care, Zoom, and Apple in the panel, 'Technology and Bold Solutions for Accessible Telehealth.' The session will focus on how big tech can drive innovations to meet the needs of patients with disabilities, aiming to improve health equity and accessibility. Amwell emphasizes improving access to quality healthcare through its WCAG-conformant platform, Amwell Converge™, featuring Interpreter Services and other accessibility functions.